Log in

MDXH MDxHealth SA NASDAQ · United States

MDxHealth SA (MDXH) news

MDxHealth SA is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MDXH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest MDxHealth SA news

We have not published a story on MDxHealth SA yet. When there is news, it will appear here.

Questions about MDxHealth SA

What is the ticker symbol of MDxHealth SA?

MDxHealth SA trades under the ticker MDXH on NASDAQ.

Where is MDxHealth SA listed?

MDxHealth SA is listed on NASDAQ.

Which country or territory is MDxHealth SA listed under?

Our directory records MDxHealth SA under United States.

Does aibio.space cover MDxHealth SA?

aibio.space lists MDxHealth SA among 2,820 public biotech companies and publishes its news here as stories appear.

Investor discussion: MDxHealth SA

Members talk about MDxHealth SA (MDXH). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at MDxHealth SA, newest first. Each line links the filing it comes from.

  1. Listings

    Reported a reverse stock split. SEC Form 6-K. Source

  2. Financings

    Reported a financing. SEC Form 6-K. Source

  3. Financings

    Reported a financing. SEC Form 6-K. Source

  4. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source

  5. Listings

    Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:MDXH on TradingView.

Listing details

MDxHealth SA is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MDXH, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
MDxHealth SA
Ticker
MDXH
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.